Clinical outcomes and pathogenetic mechanisms of adjunctive ribonucleic acid therapy in adult patients with measles during the period of increased incidence in 2025–2026. ІХ [Internet]. 2026 Sep. 30 [cited 2026 Oct. 17];(3):13-26. Available from: https://ojs.tdmu.edu.ua/inf-patol/article/view/16753